SHBG, sex hormone binding globulin, 6462

N. diseases: 368; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 GeneticVariation disease BEFREE This single nucleotide polymorphism (SNP) modified associations of soy isoflavones and tea consumption but not fiber intake with endometrial cancer, with the inverse association of soy intake and tea consumption being more evident for those with the Asp/Asp genotype of the SHBG gene at rs6259" genes_norm="6462">Asp(327)Asn (rs6259), particularly premenopausal women (P(interaction) = 0.06 and 0.02, respectively, for soy isoflavones and tea intake). 19005973 2008
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 GeneticVariation disease BEFREE DNA samples from 150 cases of endometrial cancer and healthy controls (n = 165) were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to determine the genotypic frequency of 13 different polymorphic loci on the CYP1A1 (m1, m2, m3, m4), CYP1A2 1F, CYP1B1 codon432, COMT codon158, CYP17, SULT1A1 (Arg213His, 14A/G, 85C/T in the 3' flanking region), SULT1E1-64G/A promoter region, and SHBG genes. 18318428 2008
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 AlteredExpression disease BEFREE Epidemiologic studies have demonstrated that blood SHBG levels are associated inversely with the risk of endometrial cancer. 17315164 2007
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 AlteredExpression disease BEFREE On the other hand, alteration to a relative increase in SHBG wild-type mRNA expression in the metastatic lesions occurred in only 3 cases (1/10 cases of uterine endometrial cancers and 2/10 cases of uterine cervical cancers) analyzed. 10369407 1999
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 Biomarker disease BEFREE These findings suggest that intracellular SHBG suppression might partly contribute to the abolition of the intracellular estrogen-dominant milieu, and may be involved as one of the mechanisms of the antitumoral effects of high-dose MPA on the development and growth of some well-differentiated endometrial cancer cells. 9625372 1998
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 Biomarker disease BEFREE These results suggest that dedifferentiation of endometrial cancers might induce a reduction in their estrogen-dependent properties via intracellular SHBG. 9407970 1997
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 Biomarker disease BEFREE A decrease of intracellular SHBG caused by high-dose danazol or progesterone might partly contribute to the abolition of the intracellular estrogen-dominant milieu, and be related to the inhibition of estrogen-dependent growth of some endometrial cancer cells. 9408086 1997
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.080 AlteredExpression disease BEFREE Further, it indicates that endometrial cancer cell synthesis of SHBG mRNA is lost as these cells undergo de-differentiation. 7779755 1995